铒 rod, 50mm, diameter 10.0mm, cast, 99%; CAS Number: 7440-52-0; Synonyms: 铒; find -GF21606386 MSDS, related peer-reviewed papers, technical documents, similar products & more at Sigma-Aldrich

铒 rod, 50mm, diameter 10.0mm, cast, 99% | Sigma-Aldrich

铒 rod, 50mm, diameter 10.0mm, cast, 99%

This article reviews aspects of the probable mechanisms used by erbium dental lasers for cutting dentine and enamel, describes key issues of the risk of temperature elevation and speed of cutting relative to conventional techniques and looks at issues concerned with the safety of lasers.

A review of technology and safety aspects of erbium lasers in dentistry.

There are two lasers for resurfacing. The erbium:YAG laser and the CO2 laser both have different physical and physiologic differences when striking the skin. Therefore, each laser gives a different result. This article reviews the use of the Sharplan Silktouch CO2 laser for 4 years and the erbium:YAG laser for 1 year. In the last year, we have performed 40 laser procedures with the erbium:YAG laser. Discussion ensues regarding the differences and similarities of the two lasers as well as the difficulties and complications.

Laser facial skin resurfacing: discussion on erbium:YAG and CO2 lasers.

Carbon dioxide laser resurfacing has been a valuable procedure for facial skin rejuvenation since the early 1990s, largely replacing medium and deep chemical peels and dermabrasion. The introduction of the erbium:YAG laser for resurfacing has caused confusion about its role. Because of its ability to resurface very superficially it has been limited by many laser surgeons to treating only superficial rhytides and sun damage. However, it is the equal of CO2 in improving deep rhytides but with quicker healing and fewer side-effects.

Controversies in skin resurfacing: the role of erbium.

Laser resurfacing procedures in actinic skin damage and the treatment of disorders associated with skin ageing are becoming more popular. For both purposes Erbium:YAG laser-technology enables us to perform a highly precise skin ablative work, which can be most helpful in the removal of circumscribed skin lesions of ageing skin as well as in larger skin resurfacing procedures. In most circumstances, superficial skin ablation is not technically demanding, is not associated with major discomfort, and can be controlled with precision. Tissue sparing ablation is of special value in the treatment of disorders in atrophic skin of elderly patients or in more delicate areas, where it can avoid prolonged healing and unwarranted side-effects.

Role of Erbium:YAG laser in the treatment of aged skin.

Since lasers were introduced for the treatment of oral diseases, there has been considerable advancement in technology. As a result, numerous laser systems are currently available for oral use. Neodymium:Yttrium-Aluminum:Garnet (Nd:YAG), carbon dioxide (CO(2)) laser and the semiconductor Diode lasers have already been approved by the US Food and Drug Administration for soft tissue treatment in oral cavity. The Erbium:YAG (Er:YAG) laser was approved in 1997 for hard tissue treatment in dentistry and recent studies have reported positive results. This suggests that the Er:YAG laser system is a promising apparatus, which will be able to revolutionize and improve dental practice, in particular periodontal treatment. In this mini-review, we would like to describe the positive characteristics of the Er:YAG laser which indicate its potential as a new treatment modality in periodontics. Recent findings are summarized briefly to evaluate the potential of the Er:YAG laser for clinical application in periodontics. The Er:YAG laser possesses suitable characteristics for oral soft and hard tissue ablation. Recently, it has been applied for effective elimination of granulation tissue, gingival melanin pigmentation and gingival discoloration. Contouring and cutting of bone with minimal damage and even or faster healing can also be performed with this laser. In addition, irradiation with the Er:YAG laser has a bactericidal effect with reduction of lipopolysaccharide, high ability of plaque and calculus removal, with the effect limited to a very thin layer of the surface and is effective for implant maintenance. The Er:YAG laser seems to be an effective tool for periodontal therapy, however, further clinical and basic investigations are required to confirm its clinical application.

Potential applications of Erbium:YAG laser in periodontics.

Nonablative remodeling has recently been proposed as a new antiaging treatment with no downtime. This technique could greatly benefit the increasing numbers of patients who are looking for new and efficient techniques, with a minimum of discomfort. AND METHODS. The 1.54 microm wavelength has been proposed for this application because this wavelength is well absorbed by water yet virtually not at all by melanin, allowing deep penetration into the skin. To protect the epidermis during laser irradiation, a cooling system (+5 degrees C) uses a sapphire window (purified tetrafluoroethane circulates in a pipe around the sapphire) directly applied to the skin through which the laser pulse may be fired. Several clinical trials have been published and have demonstrated that clinical improvement was correlated with data from ultrasound imaging, histology, and profilometry. A recent trial on the forehead and neck yielded additional data on elasticity measured by echorheometry. The 1.54 microm laser is safe and effective for remodeling in all of these published studies. Remodeling requires months to achieve its goal, and the kind of improvement that can be expected should be explained to the patient. Long-term follow-up showed that the improvement increased after each treatment and lasted for months after the final session.

Nonablative remodeling with a 1,540 nm erbium:glass laser.

This work presents the morphological and optical properties of luminescent silica spheres, discussing applications in bioimaging and biosensing. The spheres are obtained by the hydrolysis and condensation of tetraethylorthosilicate (TEOS) and can be synthesized by following either a basic or an acidic route. Luminescence emission is induced after incorporation of aminopropyltriethoxysilane (APTES) during synthesis or by introducing an optically active element, such as erbium, or other rare-earth elements. The luminescence properties of APTES-functionalized silica spheres have been investigated and optimized by varying the annealing temperature. On the other hand, erbium incorporation in silica spheres was also studied and the corresponding Er(3+) luminescence emission at 1.54 microm was evaluated for intensity and lifetime. The basic pH environment in the synthesis allows good control of the size of the spheres (approximately 200 nm in diameter), whereas the acidic route produces a wide dispersion in particle size (200-5000 nm). Both these approaches, however, can be followed to obtain an efficient photoluminescence (PL) emission for the APTES-functionalized silica spheres after 400-600 degrees C thermal treatment. If Er(NO(3))(3) is introduced in the basic solution, a rapid precipitation of Er(OH)(3) occurs, but erbium can be easily and efficiently incorporated in the acid-synthesized spheres, showing high PL intensity at 1.54 microm with lifetime of 3.9 ms. Finally, I discuss perspectives for the applications of these luminescent silica spheres, in particular as biological markers for bioimaging and biosensing.

Luminescent amino-functionalized or erbium-doped silica spheres for biological applications.

The short-pulsed Er:YAG laser system is an excellent ablative tool for cutaneous resurfacing. This system is most efficacious for patients with milder cutaneous involvement, including mild photoinduced facial rhytides, mildly atrophic scars, and textural changes caused by fibrosis and dermatochalasis. The Er:YAG laser cannot achieve the same dramatic clinical and histologic improvements produced with the CO2 laser but does offer some distinct advantages that make it a valuable addition to the laser surgeon's armamentarium. The Er:YAG laser, because of its higher affinity for water-containing tissues, effects a much finer level of tissue ablation. Although erbium laser resurfacing results in decreased postoperative morbidity with a shorter recovery period, it cannot effect the same degree of improvement in photodamaged skin as can the CO2 laser. Excellent results, however, can be achieved with this laser, up to 50% or more overall clinical improvement, in patients with milder photodamage and scarring (Glogau classes I and II). In darker-skinned patients, the Er:YAG laser is often the preferred treatment modality. Continued research in the field has already led to the development of longer-pulsed Er:YAG lasers, which offer a compromise between the CO2 laser and the short-pulsed Er:YAG lasers in terms of clinical benefits while maintaining the safety profile of the traditional short-pulsed system. In addition, many surgeons now use a combination approach with the CO2 and Er:YAG lasers in an effort to maximize collagen contraction in certain areas and limit postoperative morbidity. As more research is conducted within the field of cutaneous resurfacing, newer systems will be developed in the continuing effort to create the ideal laser system--one which ameliorates the signs of photoaging without risk of major side effects or significant postoperative recovery.

Erbium:YAG cutaneous laser resurfacing.

The Erbium:YAG laser is a useful flexible tool for the surgeon interested in providing overall skin rejuvenation. With its unique wavelength, greater absorption, and less thermal injury, it can offer more precise ablation with greater safety and shorter healing times. All skin types as well as all body parts can safely be treated, from simple lentigines to deeper rhytides. The Erbium:YAG laser is an effective tool for complete skin rejuvenation. System specifications and parameters are reviewed along with pathology,uses, and techniques including postoperative care, risks, and safety profile.

Erbium:YAG laser skin resurfacing.

We have synthesized Er2S3/ZnS core/shell QDs by employing ErSt3, ZnSt2, and sulfur as precursors via a hot solution phase chemistry using a nucleation-doping strategy. X-ray diffraction (XRD), transmission electron microscope (TEM) and photoluminescence (PL) spectra were used to characterize the structure, morphology and luminescence properties of Er2S3/ZnS core/shell QDs. Moreover, the influence of overcoating temperatures on the infrared luminescence properties of QDs was investigated. PL spectra show that the emission intensity from the 4I13/2 --> 4I15/2 transition of Er3+ strongly increases with increasing overcoating temperatures, which was interpreted by the enhancing diffusion of Er3+ ions. IR-LEDs were fabricated combining commercial red GaAs LEDs with Er2S3/ZnS QDs, and luminescence properties of the IR-LED have been investigated.

Efficient infrared luminescence of Er2S3/ZnS core/shell quantum dots and IR QDs-lED.

Erbium hard tissue lasers have the capability to prepare enamel, dentin, caries, cementum, and bone in addition to cutting soft tissue. The ability of hard tissue lasers to reduce or eliminate vibrations, the audible whine of drills, microfractures, and some of the discomfort that many patients fear and commonly associate with high-speed handpieces is impressive. In addition, these lasers can be used with a reduced amount of local anesthetic for many procedures. Today, these instruments have evolved from their initial use for all classes of cavity preparations to their ability for removing soft tissue, their usefulness in the disinfection of bacteria within endodontic canals, and most recently, as an alternative to the high speed handpiece for the removal of bone in oral and maxillofacial surgery. In addition, recent research has centered on the value of the erbium family of laser wavelengths in periodontics, including the removal of calculus.

Erbium lasers in dentistry.

Erbium:yttrium-aluminum-garnet (Er:YAG) cataract extraction has shown considerable promise as a new technique for lens nucleus removal prior to intraocular lens (IOL) implantation for the treatment of cataracts. Recent studies suggest that the laser energy is dissipated much more locally and heats surrounding intraocular tissues less than traditional ultrasonic phacoemulsification does. Clinical studies demonstrate the safety of the procedure in human cataract patients, and a randomized study found little difference in outcomes when compared to conventional cataract surgery. Further advances in fiber optic delivery systems and handpiece development may make this approach even more attractive in the future.

Erbium:YAG laser in cataract extraction.

In this study, chitosan functionalized LaF3:Yb,Er upconverting nanotransducers (UCNTs) with controlled size and shape have been successfully synthesized by a facile one pot precipitation method. The chitosan encapsulated UCNTs show bright upconversion fluorescence upon excitation with 974 nm NIR region. The average crystallite size of UCNTs about 7.6 nm was achieved using chitosan mediated synthesis. The FTIR result confirms the chitosan coating over the LaF3:Yb,Er nanoparticles. Due to the surface modification using natural biopolymer chitosan, the as-prepared nanocrystals show excellent biocompatibility even at high dose at 200 μg/ml. To the best of our knowledge the presented work is the first report on in vitro analysis of chitosan conjugated LaF3:Yb,Er upconverting nanocrystals in human breast (MCF-7) cancer cells. These nanotransducers can be used as luminescent probes for bioimaging and deep tissue cancer therapeutic applications.

Chitosan conjugation: a facile approach to enhance the cell viability of LaF₃:Yb,Er upconverting nanotransducers in human breast cancer cells.

Water-soluble BaYF5:Yb3+/Er3+ nanoparticles with the surface functionalized by a layer of poly(acrylic acid) (PAA) were synthesized via a facile one-step PAA-assisted hydrothermal method. Bovine serum albumin (BSA) protein was conjugated with BaYF5:Yb3+/Er3+ upconversion nanoparticles via free carboxylic acid groups on the surface of nanoparticles. The final products were characterized by X-ray diffraction (XRD), transmission electron microscopy (TEM), infrared (IR) spectrophotometry, ultraviolet (UV) spectrophotometry and photoluminescence spectroscopy (PL). The XRD results showed that PAA-capped BaYF5:Yb3+/Er3+ upconversion nanoparticles could be obtained via a PAA assisted hydrothermal process with the pH value of 8 at 200 degrees C for 24 h. The TEM results showed that the morphology of BaYF5:Yb3+/Er3+ nanoparticles was spherical particles with an average diameter of about 4 nm. The IR and UV spectra showed that BSA has been conjugated with BaYF5:Yb3+/Er3+ up-conversion nanoparticles. The luminescence properties of BaYF5:Yb3+/Er3+ up-conversion nanoparticles were also studied. The luminescence properties of the products suggest that BaYF5:Yb3+/Er3+ upconversion nanoparticles have promising applications for labels in biological assays.

Bioconjugation of poly(acrylic acid)-capped BaYF5:Yb3+/Er3+ up-conversion nanoparticles to bovine serum albumin: synthesis and photoluminescent properties.

We have studied the growth behaviour of sub-10 nm NaYF₄ upconversion nanocrystals of the hexagonal β-phase and the cubic α-phase. Ostwald-ripening of such particles in oleic acid/octadecene solvent results in broadening of the particle size distribution if the colloid contains particles of one crystal phase only. Narrow size distributions are formed only if β-phase particles grow in the presence of an excess of α-phase particles. Such binary mixtures of α-phase and β-phase particles form intrinsically when colloids of α-phase particles are heated for a sufficiently long time, because seeds of the β-phase nucleate in the solution after some time at high temperatures. Since the number of seeds determines the final size of the β-phase product, control of the nucleation is crucial for controlling the final particle size. We show that the number of β-phase seeds strongly depends on the composition of the α-phase known to form solid solutions Na₁-xYF₄-x in the range from x = 0 to x = 4/9. Sodium-deficient α-phase particles form a negligible number of β-phase seeds whereas α-phase particles with high sodium content yield a very large number of seeds. By taking advantage of this dependence and modifying the synthesis of the α-phase particles accordingly, small phase-pure β-NaYF₄:Yb,Er particles with a size smaller than 6 nm can be prepared in oleic acid/octadecene just as well as much larger particles.

Ostwald-ripening and particle size focussing of sub-10 nm NaYF₄ upconversion nanocrystals.

In this work, we described one pot hydrothermal synthesis of surface modified water soluble YF3: Yb, Er upconverting nanofluorophores (UCNFs) using natural biopolymer chitosan. The obtained nanocrystals have undergone X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), energy dispersive spectroscopy (EDS), high resolution transmission electron microscopy (HRTEM) and photoluminescence (PL) studies. The nanoparticles possess uniform particle size distribution with average size about 27 nm. The cytotoxicity results revealed that the chitosan capped nanoparticles exhibit excellent biocompatibility in human breast cancer cells. In conclusion, the water soluble chitosan capped YF3: Yb, Er nanoparticles could be used as a potential candidate in bio-imaging and therapeutic applications.

Synthesis of YF3: Yb, Er upconverting nanofluorophores using chitosan and their cytotoxicity in MCF-7 cells.

Nanosized rare earth (RE) hydroxides including La(OH)3, Nd(OH)3, Pr(OH)3, Sm(OH)3, Gd(OH)3, and Er(OH)3 with rod-like morphology are fabricated via a convenient hydrothermal approach. This strategy calls for the first preparation of metal complexes between RE precursors and dodecylamine (DDA) in water/ethanol mixture at room temperature and subsequent thermal decomposition at elevated temperature. The influence of reaction time and water/ethanol volume ratios on the morphology and size of as-prepared RE hydroxides are investigated. CeO2 nanoparticles with spherical shape could be directly obtained by hydrothermal treatment of complexes formed between Ce precursors and DDA. In addition, by further calcinating the RE hydroxides at high temperature in air, RE oxide nanorods could be readily produced.

A facile hydrothermal approach to the synthesis of nanoscale rare earth hydroxides.

The advent of flexible optoelectronic devices has accelerated the development of semiconducting polymeric materials. We seek to replace conventional expensive semiconducting photodetector materials with our cost-effective composite system. We demonstrate in this work the successful fabrication of a photoconductive composite film of poly(3-hexylthiophene-2,5-diyl) (P3HT) mixed with NaYF4:Yb,Er nanophosphors that exhibited a ultrahigh photoresponse to infrared radiation. The high photocurrent measured was enabled by the unique upconversion properties of NaYF4:Yb,Er nanophosphors, where low photon energy infrared excitations are converted to high photon energy visible emissions that are later absorbed by P3HT. Here we report, a significant 1.10 × 10(5) times increment of photocurrent from our photoconductive composite film upon infrared light exposure, which indicates high optical-to-electrical conversion efficiency. Our reported work lays the groundwork for the future development of printable, portable flexible and functional photonic composites for light sensing and harvesting, photonic memory devices, and phototransistors.

Cost-Effective and Highly Photoresponsive Nanophosphor-P3HT Photoconductive Nanocomposite for Near-Infrared Detection.

To perform a systemic review and meta-analysis on the effectiveness of radiosynoviorthesis (RSO). A search of medical databases was conducted. Criteria for inclusion: articles in English, minimum follow-up of 6 months, specification of joint disease, reported outcome of at least 5 RSOs. The studies were scored for quality by the Oxford Centre of Evidenced-based Medicine Levels of Evidence, from 1 to 4. Twenty-one (21) studies were included (3 quality 1b, 5 2b and 13 4), analysing 169Erbium/186Rhenium-RSO used predominantly in small joints and 49 (1 quality 1b, 10 2b and 38 4) on 90Yttrium-RSO used predominantly in knee joints. The reported success rates of 169Erbium/186Rhenium-RSO ranged from 69-100% at 6 months, and from 54-100% at > or =12 months; for 90Yttrium they were 24-100% and 29-94%, res-pectively. Studies comparing the effect of RSO with that of glucocorticoid (GC) or saline injection alone were pooled. At 6 months, the pooled odds ratio favouring RSO of the knee with Yttrium over control is 4 (confidence interval (CI) 95% 1.2-14), p=0.02, but at 12 months the ratio was 1.7 (CI95% 0.69-4), p=0.26. For RSO of small joints with Erbium/Rhenium compared to controls, the pooled odds ratio at 6 months is 2 (CI95% 0.66-6), p=0.22 and at 12 months 2 (CI95% 1.09-3.5), p=0.03. Reported success rates of RSO are high, but differences in effect with GC injection are less evident, although there is marked heterogeneity in study design of the (small number of) comparative studies.

Radiation synovectomy with (90)Yttrium, (186)Rhenium and (169)Erbium: a systematic literature review with meta-analyses.

It is difficult to control the electrophoretic mobility in order to obtain high resolution among saccharides in complex samples. We report herein on a new affinity capillary electrophoresis (ACE) method for an anionic monosaccharide, N-acetylneuraminic acid (Neu5Ac), which is important in terms of pathological diagnosis, using lanthanide-hexadentate macrocyclic polyazacarboxylate complexes (Ln-NOTA) as affinity reagents. It was shown that Ln-NOTA complexes increased the anionic mobility of Neu5Ac by approximately 40% through selective complexation with Neu5Ac. The extent of change in the mobility strongly depended on the type of central metal ion of Ln-NOTA. The stability constant (K) of Lu-NOTA with Neu5Ac was determined by ACE to be log Kb = 3.62 ± 0.04, which is the highest value among artificial receptors for Neu5Ac reported so far. Using this ACE, the Neu5Ac content in a glycoprotein sample, α1-acid glycoprotein (AGP), was determined after acid hydrolysis. Complete separation between Neu5Ac and hydrolysis products was successful by controlling the mobility to determine the concentration of Neu5Ac.

Affinity Capillary Electrophoresis for Selective Control of Electrophoretic Mobility of Sialic Acid Using Lanthanide-Hexadentate Macrocyclic Polyazacarboxylate Complexes.

铒

rod, 50mm, diameter 10.0mm, cast, 99%

属性

测定

形式

manufacturer/tradename

电阻率

长度 × 直径

bp

mp

密度

SMILES string

InChI

InChI key

相关类别

说明

一般描述

法律信息

安全信息

储存分类代码

WGK

闪点(F)

闪点(C)

文件

分析证书

原产地证书 (CofO)

更多文件

报价与订购

同行评审论文

技术服务